Recent Posts on This Topic | See All >
InNexus primate study clears way for human trials on non-Hodgkins lymphoma tumorsTags: clinical trials
[Source: Phoenix Business Journal - by Angela Gonzales] - InNexus Biotechnology Inc. has completed a primate study it says confirms the effectinvess and safety of its treatment for non-Hodgkins lymphoma tumors.
The Toronto, Canadian company (TSX:IXS.V), whose business offices are based in Scottsdale, also scheduled a meeting with the U.S. Food and Drug Administration to discuss the design of a clinical study on humans.
For more information click here.
“Arizona’s Bioscience Roadmap 2014-2025: Advancing the Biosciences and Improving Health Outcomes,” is available along with its supplement, “Summary of Goals, Strategies, and Potential Actions.” The updated Roadmap provides a long-term strategy for Arizona to achieve bioscience success over the next decade. Also, discover The State of Bioscience.